Recently in the news through another division, Johnson and Johnson won a large court case so perhaps some of the awarded money in the “stent wars” could be going to pay fines? Johnson and Johnson Revenue Increased – Helped Along with “Stent War” Settlements Also, the company has faced additional competition...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Apr 29 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Marketing, Johnson and Johnson, Lawsuits, off label prescribing, stent wars, Ortho-McNeil Jansssen
Depressed cheer leaders, that one sounds like right out of the OC. Look at the one comment below, “targeted doctors would see 2 or 3 different Pfizer reps a day”, that is a lot, and they are out there, I see them all over and maybe a bit of duplicated effort, but they all seem to bring lunch! ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Sep 9 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Pharma, Viagra, Pfizer, Heatlhcare, Lawsuits, Zoloft, whistelblower
Legal suits are still ramped with drug companies in the court rooms, this one has to be one of the largest settlements I am aware of, over a billion dollar infringement over the patent, or aka Intellectual Property as sometimes referred to today. The two drugs in question were Humira from Abbott...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jun 30 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Prescriptions, Patents, Johnson and Johnson, Intellectual property, Lawsuits, Abbott Labs
With our new administration, this is getting to be real heated topic and everyone has their points. Right now with some medications not having a generic equivalent, patents are being challenged to bring a generic to market sooner. One of the oldest methods used for years has been to –re-invent...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Mar 29 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Genomics, healthcare, Pharma, Generic Drugs, warfarin, NIH, Lawsuits, blood thinners, Plavix, Bristol-Myer Squibb
It doesn’t appear that any pharma company has not been involved in a lawsuit over Off Label Marketing and now it’s J and J’s turn. Recent settlements have generated some large sums of money of late. Algorithms and whistleblowers still continue to be the two Hot Words in Healthcare. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 23 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, FDA, Johnson and Johnson, Lawsuits, Off Label Drug use, Whistleblowers, DOJ
The entire focus is to see whether or not patent laws have been violated and if less expensive generics were in any way stalled from getting to the market place. It all boils down to intellectual-property rights and patient disputes. Interesting that Teva is settling lawsuits and will be...
This court case has been in the news of late and now with the current ruling, it adds on one more layer of responsibility to the Name Brand drug company, in other words when the generic versions come out and are prescribed, they can piggyback the exact same warnings, thus the name brand company is now...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Nov 18 2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Pharma, Heatlhcare, Side Effects, Warnings, Lawsuits, liability, Generice drugs, drugs. name band drugs